Principal Financial Group’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-15,051
Closed -$135K 2297
2016
Q3
$135K Hold
15,051
﹤0.01% 2082
2016
Q2
$81K Buy
15,051
+1,169
+8% +$5.99K ﹤0.01% 2106
2016
Q1
$64K Buy
13,882
+266
+2% +$1.07K ﹤0.01% 2114
2015
Q4
$71K Hold
13,616
﹤0.01% 2129
2015
Q3
$82K Buy
13,616
+1,439
+12% +$17.6K ﹤0.01% 2103
2015
Q2
$192K Buy
+12,177
New +$148K ﹤0.01% 2050
2015
Q1
Sell
-18,270
Closed -$192K 2260
2014
Q4
$192K Buy
18,270
+6,569
+56% +$64.2K ﹤0.01% 2048
2014
Q3
$112K Buy
11,701
+218
+2% +$2.23K ﹤0.01% 2129
2014
Q2
$133K Buy
+11,483
New +$105K ﹤0.01% 2165
2014
Q1
Sell
-16,539
Closed -$215K 2360
2013
Q4
$215K Hold
16,539
﹤0.01% 2125
2013
Q3
$247K Buy
+16,539
New +$198K ﹤0.01% 2028

Principal Financial Group's RPTP Position: Q4 2016 in Review

Principal Financial Group sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 15,051 shares — an estimated $135K sold.

Principal Financial Group first reported a position in RPTP in Q3 2013 and held it in 11 quarters. The position peaked at $247K in Q3 2013. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.

  • Principal Financial Group reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
  • Principal Financial Group sold 15,051 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $135K.
  • Principal Financial Group first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q3 2013 and held it in 11 quarters.
  • Principal Financial Group's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $247K in Q3 2013.
  • 0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.

Based on Principal Financial Group's 13F filing for Q4 2016, filed 13 Feb 2017.